Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue
- 9 December 2011
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 42 (8) , 1591-1603
Abstract
Background: Interferon-alpha (IFN-α) treatment for infectious disease and cancer causes high rates of depression and fatigue, and has been used to investigate the impact of inflammatory cytokines on brain and behavior. However, little is known about the transcriptional impact of chronic IFN-α on immune cellsin vivoand its relationship to IFN-α-induced behavioral changes.Method: Genome-wide transcriptional profiling was performed on peripheral blood mononuclear cells (PBMCs) from 21 patients with chronic hepatitis C virus (HCV) either awaiting IFN-α therapy (n=10) or at 12 weeks of IFN-α treatment (n=11).Results: Significance analysis of microarray data identified 252 up-regulated and 116 down-regulated gene transcripts. Of the up-regulated genes, 2′-5′-oligoadenylate synthetase 2 (OAS2), a gene linked to chronic fatigue syndrome (CFS), was the only gene that was differentially expressed in patients with IFN-α-induced depression/fatigue, and correlated with depression and fatigue scores at 12 weeks (r=0.80,p=0.003 andr=0.70,p=0.017 respectively). Promoter-based bioinformatic analyses linked IFN-α-related transcriptional alterations to transcription factors involved in myeloid differentiation, IFN-α signaling, activator protein-1 (AP1) and cAMP responsive element binding protein/activation transcription factor (CREB/ATF) pathways, which were derived primarily from monocytes and plasmacytoid dendritic cells. IFN-α-treated patients with high depression/fatigue scores demonstrated up-regulation of genes bearing promoter motifs for transcription factors involved in myeloid differentiation, IFN-α and AP1 signaling, and reduced prevalence of motifs for CREB/ATF, which has been implicated in major depression.Conclusions: Depression and fatigue during chronic IFN-α administration were associated with alterations in the expression (OAS2) and transcriptional control (CREB/ATF) of genes linked to behavioral disorders including CFS and major depression, further supporting an immune contribution to these diseases.Keywords
This publication has 72 references indexed in Scilit:
- Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigueBrain, Behavior, and Immunity, 2011
- Fatigue and gene expression in human leukocytes: Increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigueBrain, Behavior, and Immunity, 2011
- Decreased immobility in swimming test by homologous interferon-α in mice accompanied with increased cerebral tryptophan level and serotonin turnoverNeuroscience Letters, 2009
- Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and DepressionBiological Psychiatry, 2009
- Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interfaceBrain, Behavior, and Immunity, 2009
- Depression, social support, and beta-adrenergic transcription control in human ovarian cancerBrain, Behavior, and Immunity, 2009
- A Functional Genomic Fingerprint of Chronic Stress in Humans: Blunted Glucocorticoid and Increased NF-κB SignalingBiological Psychiatry, 2008
- IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis CBrain, Behavior, and Immunity, 2008
- Interferon-α effects on diurnal hypothalamic–pituitary–adrenal axis activity: relationship with proinflammatory cytokines and behaviorMolecular Psychiatry, 2008
- The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueJournal of Psychosomatic Research, 1995